2019 Thai Guidelines on the Treatment of Hypertension: Executive Summary

Kunanon, Sirisawat; Chattranukulchai, Pairoj; Chotruangnapa, Chavalit; Kositanurit, Weerapat; Methavigul, Komsing; Boonyasirinant, Thananya; Rawdaree, Petch; Tejavanija, Sirakarn; Wataganara, Tuangsit; Satirapoj, Bancha; Roubsanthisuk, Weranuj; Suwanwela, Nijasri C.; Sangwatanaroj, Somkiat; Ayudhya, Rapeephon Kunjara Na; Sitthisook, Surapun; Sukonthasarn, Apichard

doi:10.35755/jmedassocthai.2021.10.12199

Cited by 24 publications

(11 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The BP information in the latest visit was also collected. Control BP was defined as systolic BP (SBP) < 140 mmHg and diastolic BP (DBP) < 90 mmHg [ 12 ]. The data on the use of antihypertensive medication was available only for the years 2014, 2015, and 2018.…”

Section: Methodsmentioning

confidence: 99%

“…Whereas the Utrecht Health Project pointed out that routinely recording an electrocardiography (ECG) in unselected hypertension patients is considerable, the number needed to screen to prevent one death is lower than that in other widely accepted tests [ 11 ]. In Thailand, the Thai guideline for treating hypertension recommended that all Thai patients with hypertension should receive 12-lead ECG screening to detect ECG abnormalities [ 12 ].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Factors associated with electrocardiographic left ventricular hypertrophy among patients with hypertension in Thailand

Sakboonyarat,

Poovieng,

Rangsin

2024

Clin Hypertens

View full text Add to dashboard Cite

Background Left ventricular hypertrophy (LVH) strongly predicts cardiovascular diseases (CVD) and death. One-fourth of Thai adults suffer from hypertension. Nevertheless, the information on LVH among Thai patients with hypertension is not well characterized. We aimed to identify the prevalence and factors associated with electrocardiographic LVH (ECG-LVH) among patients with hypertension in Thailand. Methods The present study obtained the dataset from the Thailand Diabetes Mellitus/Hypertension study, which included hypertension patients aged 20 years and older receiving continuous care at outpatient clinics in hospitals nationwide in 2011–2015 and 2018. Meanwhile, those without a record of 12-lead electrocardiography (ECG) were excluded from the analysis. ECG-LVH was defined as the LVH noted regarding ECG interpretation in the medical records. Multivariable logistic regression analysis was utilized for determining factors associated with ECG-LVH and presented as the adjusted odds ratio (AOR) and 95% confidence interval (CI). Results From 226,420 hypertensive patients in the Thailand Diabetes Mellitus/Hypertension study, 38,807 individuals (17.1%) with ECG data recorded were included in the analysis. The mean age was 64.8 ± 11.5 years, and 62.2% were women. Overall, 1,557 study participants had ECG-LVH, with an estimated prevalence of 4.0% (95% CI, 3.8–4.2%). Age-adjusted ECG-LVH prevalence among women and men was 3.4 and 5.1%, respectively (P < 0.001). Multivariable analysis determined factors associated with ECG-LVH, including being men (AOR, 1.49; 95% CI, 1.31–1.69), individuals aged 70 to 79 years (AOR, 1.56; 95% CI, 1.20–2.02) and ≥ 80 years (AOR, 2.10; 95% CI, 1.58–2.78) compared to individuals aged less than 50 years, current smokers (AOR, 1.26; 95% CI, 1.09–1.46) compared to those who never smoked, systolic blood pressure ≥ 140 mmHg and diastolic blood pressure ≥ 90 mmHg (AOR, 1.58; 95% CI, 1.30–1.92) compared to systolic blood pressure < 140 mmHg and diastolic blood pressure < 90 mmHg. Conclusions The current study illustrated the prevalence of ECG-LVH among Thai patients with hypertension who had ECG recorded and identified high-risk groups who tended to have ECG-LVH. The findings underscore the need for targeted interventions, particularly among high-risk groups such as older individuals, men, and current smokers, to address modifiable factors associated with ECG-LVH.

show abstract

Section: Methodsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Factors associated with electrocardiographic left ventricular hypertrophy among patients with hypertension in Thailand

Sakboonyarat,

Poovieng,

Rangsin

2024

Clin Hypertens

View full text Add to dashboard Cite

show abstract

“…BMI was calculated as weight in kilograms by height in meters squared. BP was measured by an operator trained in standardized technique following the 2019 Thai Treatment Guidelines of HT [ 36 ], through the use of an automatic BP monitor (OMRON model HEM-8712, Kyoto, Japan).…”

Section: Methodsmentioning

confidence: 99%

Effect of the weight-loss program using daily self-weighing combined with personalized counseling led by village health volunteers in adults with obesity in a rural community, Thailand: a randomized controlled trial

Liampeng,

Wongkliawrian,

Junlawakkananon

et al. 2023

BMC Prim. Care

View full text Add to dashboard Cite

Background In a remote rural community in central Thailand, obesity prevalence among adults significantly rose from 33.9% in 2012 to 44.8% in 2018. Limited information on weight reduction studies in Thai rural communities was available. The present study aims to evaluate the effect of daily self-weighing combined with personalized counseling in order to reduce body weight (BW) and body mass index (BMI) as well as blood pressure (BP). Methods A randomized controlled trial was carried out in a rural community in central Thailand. One-hundred and seven adults were randomly allocated (1:2) to intervention and control groups. For 20 weeks, participants in the weight-loss program performed self-weighing twice daily and recorded their weight on the calendar. The program also offers weekly counseling visits by village health volunteers (VHV) who make home visits to participants. The primary outcomes were differences in mean change in BW at 20 weeks from baseline between the intervention and control groups. Results A total of 107 participants were initially recruited. Of these, 36 participants were allocated to the intervention group and 57 participants to the control group. Significant differences in mean change in BW and BMI at the twelve-, sixteen-, and twenty-week follow-up from baseline between the two groups were observed. At twenty weeks, the mean change in BW was -1.2 kg (95% CI: -2.2, -0.3) and 0.3 kg (95% CI: -0.3, 0.8) in the intervention and control groups, respectively, with p-value = 0.007. Over 20 weeks of the study period, the estimated mean change in BW among the intervention group was 1.0 kg (95% CI -1.7, -0.2) lower than in the control group, with p-value = 0.015. Furthermore, changes in mean BMI and BP over the 20-week follow-up period in intervention participants were recognized. Conclusions Our study demonstrates that daily self-weighing combined with personalized counseling led by VHV is feasible and can induce weight loss among adults with obesity in a rural community. In addition, the weight-loss program may be a promising additional tool for reducing BP. Trial registration Trial identification number was TCTR20201020004; first submitted date: 20/10/2020.

show abstract

“…Not all hypertensive patients should be evaluated for secondary hypertension. Essential clues for suggesting a secondary condition are (a) young patient <40 years of age, (b) moderate to severe hypertension (systolic BP ≥ 160 or diastolic BP ≥ 100 mmHg) or resistant hypertension, and (c) symptoms or signs suggesting secondary causes [ 39 ]. Patients with known secondary hypertension, such as those with primary aldosteronism, Cushing’s syndrome, or renal artery stenosis, have generally been excluded from RDN trials and registries; thus, data on the efficacy of RDN in these groups of patients are lacking.…”

Section: Introductionmentioning

confidence: 99%

“…Single-pill combination drugs and polypills have been recommended to improve medication adherence and BP control in hypertension [ 27 ]. Thai Hypertension Society guidelines on the treatment of hypertension also suggest using single-pill combination drugs for treating hypertension in the Thai population [ 39 ]. However, the prescription of single-pill combination drugs is extremely low in governmental hospitals of different sizes in Thailand [ 57 ].…”

Section: Introductionmentioning

confidence: 99%

2022 Renal denervation therapy for the treatment of hypertension: a statement from the Thai Hypertension Society

Roubsanthisuk

Kunanon²,

Chattranukulchai³

et al. 2023

Hypertens Res

View full text Add to dashboard Cite

Hypertension remains a significant risk factor for major cardiovascular events worldwide. Poor adherence to treatment is extremely common in clinical practice, leading to uncontrolled hypertension. However, some patients with resistant hypertension still have uncontrolled blood pressure despite good medical compliance. A specific group of patients also develop adverse reactions to many blood pressure-lowering medications. These scenarios indicate that innovative strategies to lower blood pressure in challenging cases of hypertension are needed. The blood pressure-lowering efficacy of catheter-based renal denervation therapy to decrease sympathetic tone has been confirmed in many publications in recent years. Apart from both the invasiveness and the expensiveness of this technology, appropriate case selection to undergo this procedure is still developing. The utilization of renal denervation therapy for hypertension treatment in Thailand has lasted for 10 years with a good response in most cases. Currently, only certain interventionists at a few medical schools in Thailand can perform this procedure. However, more physicians are now interested in applying this technology to their patients. The Thai Hypertension Society Committee has reviewed updated information to provide principles for the appropriate utilization of renal denervation therapy. The blood pressure-lowering mechanism, efficacy, suitable patient selection, pre- and postprocedural assessment and procedural safety of renal denervation are included in this statement.

show abstract

2019 Thai Guidelines on the Treatment of Hypertension: Executive Summary

Cited by 24 publications

References 0 publications

Factors associated with electrocardiographic left ventricular hypertrophy among patients with hypertension in Thailand

Factors associated with electrocardiographic left ventricular hypertrophy among patients with hypertension in Thailand

Effect of the weight-loss program using daily self-weighing combined with personalized counseling led by village health volunteers in adults with obesity in a rural community, Thailand: a randomized controlled trial

2022 Renal denervation therapy for the treatment of hypertension: a statement from the Thai Hypertension Society

Contact Info

Product

Resources

About